Brazilian Resources Could Drive Equipment Sales?
Brazil's mining sector is forecasting over $64 billion in new investments, boosting demand for the essential tools and technologies that drive it. This basket provides exposure to the US/EU-listed industrial and tech giants supplying the equipment and services for Brazil's resource boom.
Your Basket's Financial Footprint
Market capitalisation breakdown shows a total of 576,128.2 with concentration in the largest constituents, indicating large-cap dominance.
- Performance & Risk: Large-cap dominance generally implies lower volatility and closer tracking of broad market performance.
- Portfolio Role: Use as a core, long-term holding for portfolio stability rather than a speculative trade.
- Growth Expectations: Expect steady, long-term value appreciation rather than short-term explosive gains.
CAT: $273.19B
DE: $125.81B
CMI: $60.36B
- Other
About This Group of Stocks
Our Expert Thinking
Brazil's mining sector is set for massive expansion with over $64 billion in new investments through 2028. Rather than betting on individual mines or commodity prices, this strategy focuses on the essential suppliers—the global companies providing the machinery, technology, and services that make modern mining possible.
What You Need to Know
This group targets the 'picks and shovels' approach to investing in Brazil's mining boom. These are established US and European-listed industrial giants that supply heavy equipment, automation technology, and specialised services to mining operations worldwide, offering exposure to growth with reduced commodity price volatility.
Why These Stocks
Each company was selected for its crucial role in modern mining operations. From manufacturers of autonomous haul trucks to developers of mine-management software, these firms provide the essential tools that improve efficiency, safety, and environmental compliance—making them indispensable to Brazil's mining modernisation.
Why You'll Want to Watch These Stocks
Riding the $64 Billion Wave
Brazil's mining sector is about to unleash over $64 billion in new investments through 2028. These companies are perfectly positioned to supply the essential equipment and technology needed for this massive expansion.
The Future of Mining is Here
From autonomous haul trucks to AI-powered mine management systems, these firms are at the forefront of mining innovation. As Brazil modernises its operations, demand for cutting-edge technology is set to soar.
Safer Than Commodity Gambling
Instead of betting on volatile commodity prices, you're investing in the companies that profit regardless of whether copper goes up or iron ore goes down. They're the essential suppliers that mining operations simply can't do without.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Automotive Semiconductor Gap Explained | Market Shift
A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.
Brazil Smart Farming Tech Investment Basket 2025
As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.
Weight-Loss Drug M&A: Valuation Risk Concerns
Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.